Steven Mento, PhD, Co-Founder, President & CEO, Conatus Pharmaceuticals, addresses the need for a better understanding of the causes of liver disease. Conatus’s latest project, Emricasan, a therapy for acute-on chronic liver failure, impacts the two underlying causes that lead to liver failure, inflammation and apoptosis.